Lipoxygenase metabolism of arachidonic acid in ischemic preconditioning and PKC-induced protection in heart

Weina Chen, Wayne Glasgow, Elizabeth Murphy, Charles Jr Steenbergen

Research output: Contribution to journalArticle

Abstract

We tested the hypothesis that activation of the 12-lipoxygenase (12-LO) pathway of arachidonic acid metabolism contributes to the protective effect of protein kinase C (PKC) activation and ischemic preconditioning (PC), and we report, in perfused rat heart, that both PC and the PKC activator 1,2- dioctanoyl-sn-glycerol (DOG) confer a similar protective effect and stimulate a comparable accumulation of 12-LO metabolites. The 12-LO product, 12(S)- hydroxyeicosatetraenoic acid [12(S)-HETE], was increased in DOG-treated (22.8 ± 4.4 ng/g wet wt) and PC hearts (26.8 ± 5.5 ng/g wet wt) compared with control (13.8 ± 2.1 ng/g wet wt, P <0.05), and this increase was blocked by 12-LO or PKC inhibitors. Both DOG pretreatment and PC improved recovery of left ventricular developed pressure (LVDP) nearly twofold after 20 min of ischemia; this improvement was blocked by 12-LO inhibitors and was mimicked by infusion of 12-hydroperoxyeicosatetraenoic acid [12(S)HpETE; 67 ± 6% recovery of LVDP vs. 35 ± 3% for untreated hearts]. Also, the protection afforded by 12(S)-HpETE, as well as by PC, was attenuated by the K+-channel blocker 5-hydroxydecanoate, suggesting that the downstream mechanisms of 12(S)-HpETE-mediated protection are similar to PC. Furthermore, PC stimulates 12-LO metabolism in perfused rabbit heart, and 12-LO inhibition blocks PC- induced cardioprotection. Thus the data suggest that 12-LO metabolism plays an important role in cardioprotection.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume276
Issue number6 45-6
StatePublished - Jun 1999
Externally publishedYes

Fingerprint

Arachidonate Lipoxygenases
Arachidonate 12-Lipoxygenase
Ischemic Preconditioning
Protein Kinase C
Ventricular Pressure
Glycerol
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
Lipoxygenase Inhibitors
Protein C Inhibitor
Protein Kinase Inhibitors
Ischemia
Rabbits
Acids

Keywords

  • 12(S)-hydroperoxyeicosatetraenoic acid
  • 12-lipoxygenase
  • Eicosanoids

ASJC Scopus subject areas

  • Physiology

Cite this

Lipoxygenase metabolism of arachidonic acid in ischemic preconditioning and PKC-induced protection in heart. / Chen, Weina; Glasgow, Wayne; Murphy, Elizabeth; Steenbergen, Charles Jr.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 276, No. 6 45-6, 06.1999.

Research output: Contribution to journalArticle

@article{e3898fe596d34f5abc6bac2ac59d5441,
title = "Lipoxygenase metabolism of arachidonic acid in ischemic preconditioning and PKC-induced protection in heart",
abstract = "We tested the hypothesis that activation of the 12-lipoxygenase (12-LO) pathway of arachidonic acid metabolism contributes to the protective effect of protein kinase C (PKC) activation and ischemic preconditioning (PC), and we report, in perfused rat heart, that both PC and the PKC activator 1,2- dioctanoyl-sn-glycerol (DOG) confer a similar protective effect and stimulate a comparable accumulation of 12-LO metabolites. The 12-LO product, 12(S)- hydroxyeicosatetraenoic acid [12(S)-HETE], was increased in DOG-treated (22.8 ± 4.4 ng/g wet wt) and PC hearts (26.8 ± 5.5 ng/g wet wt) compared with control (13.8 ± 2.1 ng/g wet wt, P <0.05), and this increase was blocked by 12-LO or PKC inhibitors. Both DOG pretreatment and PC improved recovery of left ventricular developed pressure (LVDP) nearly twofold after 20 min of ischemia; this improvement was blocked by 12-LO inhibitors and was mimicked by infusion of 12-hydroperoxyeicosatetraenoic acid [12(S)HpETE; 67 ± 6{\%} recovery of LVDP vs. 35 ± 3{\%} for untreated hearts]. Also, the protection afforded by 12(S)-HpETE, as well as by PC, was attenuated by the K+-channel blocker 5-hydroxydecanoate, suggesting that the downstream mechanisms of 12(S)-HpETE-mediated protection are similar to PC. Furthermore, PC stimulates 12-LO metabolism in perfused rabbit heart, and 12-LO inhibition blocks PC- induced cardioprotection. Thus the data suggest that 12-LO metabolism plays an important role in cardioprotection.",
keywords = "12(S)-hydroperoxyeicosatetraenoic acid, 12-lipoxygenase, Eicosanoids",
author = "Weina Chen and Wayne Glasgow and Elizabeth Murphy and Steenbergen, {Charles Jr}",
year = "1999",
month = "6",
language = "English (US)",
volume = "276",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6 45-6",

}

TY - JOUR

T1 - Lipoxygenase metabolism of arachidonic acid in ischemic preconditioning and PKC-induced protection in heart

AU - Chen, Weina

AU - Glasgow, Wayne

AU - Murphy, Elizabeth

AU - Steenbergen, Charles Jr

PY - 1999/6

Y1 - 1999/6

N2 - We tested the hypothesis that activation of the 12-lipoxygenase (12-LO) pathway of arachidonic acid metabolism contributes to the protective effect of protein kinase C (PKC) activation and ischemic preconditioning (PC), and we report, in perfused rat heart, that both PC and the PKC activator 1,2- dioctanoyl-sn-glycerol (DOG) confer a similar protective effect and stimulate a comparable accumulation of 12-LO metabolites. The 12-LO product, 12(S)- hydroxyeicosatetraenoic acid [12(S)-HETE], was increased in DOG-treated (22.8 ± 4.4 ng/g wet wt) and PC hearts (26.8 ± 5.5 ng/g wet wt) compared with control (13.8 ± 2.1 ng/g wet wt, P <0.05), and this increase was blocked by 12-LO or PKC inhibitors. Both DOG pretreatment and PC improved recovery of left ventricular developed pressure (LVDP) nearly twofold after 20 min of ischemia; this improvement was blocked by 12-LO inhibitors and was mimicked by infusion of 12-hydroperoxyeicosatetraenoic acid [12(S)HpETE; 67 ± 6% recovery of LVDP vs. 35 ± 3% for untreated hearts]. Also, the protection afforded by 12(S)-HpETE, as well as by PC, was attenuated by the K+-channel blocker 5-hydroxydecanoate, suggesting that the downstream mechanisms of 12(S)-HpETE-mediated protection are similar to PC. Furthermore, PC stimulates 12-LO metabolism in perfused rabbit heart, and 12-LO inhibition blocks PC- induced cardioprotection. Thus the data suggest that 12-LO metabolism plays an important role in cardioprotection.

AB - We tested the hypothesis that activation of the 12-lipoxygenase (12-LO) pathway of arachidonic acid metabolism contributes to the protective effect of protein kinase C (PKC) activation and ischemic preconditioning (PC), and we report, in perfused rat heart, that both PC and the PKC activator 1,2- dioctanoyl-sn-glycerol (DOG) confer a similar protective effect and stimulate a comparable accumulation of 12-LO metabolites. The 12-LO product, 12(S)- hydroxyeicosatetraenoic acid [12(S)-HETE], was increased in DOG-treated (22.8 ± 4.4 ng/g wet wt) and PC hearts (26.8 ± 5.5 ng/g wet wt) compared with control (13.8 ± 2.1 ng/g wet wt, P <0.05), and this increase was blocked by 12-LO or PKC inhibitors. Both DOG pretreatment and PC improved recovery of left ventricular developed pressure (LVDP) nearly twofold after 20 min of ischemia; this improvement was blocked by 12-LO inhibitors and was mimicked by infusion of 12-hydroperoxyeicosatetraenoic acid [12(S)HpETE; 67 ± 6% recovery of LVDP vs. 35 ± 3% for untreated hearts]. Also, the protection afforded by 12(S)-HpETE, as well as by PC, was attenuated by the K+-channel blocker 5-hydroxydecanoate, suggesting that the downstream mechanisms of 12(S)-HpETE-mediated protection are similar to PC. Furthermore, PC stimulates 12-LO metabolism in perfused rabbit heart, and 12-LO inhibition blocks PC- induced cardioprotection. Thus the data suggest that 12-LO metabolism plays an important role in cardioprotection.

KW - 12(S)-hydroperoxyeicosatetraenoic acid

KW - 12-lipoxygenase

KW - Eicosanoids

UR - http://www.scopus.com/inward/record.url?scp=0033042426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033042426&partnerID=8YFLogxK

M3 - Article

C2 - 10362692

AN - SCOPUS:0033042426

VL - 276

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 6 45-6

ER -